Rosen, skilled investor counsel, encourages lifecore biomedical inc. f/k/a landec corporation investors to inquire about securities class action investigation - lfcr, lndc

New york , april 19, 2024 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of lifecore biomedical inc. f/k/a landec corporation (nasdaq: lfcr, lndc) resulting from allegations that lifecore biomedical may have issued materially misleading business information to the investing public. so what: if you purchased lifecore biomedical securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
LFCR Ratings Summary
LFCR Quant Ranking